Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 10, 2015, Pages 19200-19211

  Liao, Pei Juan ^a   Xie, Rui Bin ^b   Yin, Rui Xing ^a   Wei, Dai Xun ^c   Huang, Jian ^d   Huang, Feng ^a   Li, Hui ^a   Lin, Wei Xiong ^a   Wu, Jin Zhen ^a   Pan, Shang Ling ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Hezhou People s Hospital   (China)

^c The Disease Control and Prevention Center   (China)

^d Department of General Practice   (China)

Author keywords

Apolipoproteins; Dyslipidemia; Lipids; Prevalence; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; ETHNIC GROUP; FEMALE; GENDER; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SMOKING; VERY ELDERLY; WAIST CIRCUMFERENCE;

EID: 84949654219     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26: 478-84.
2. Stone NJ, Robinson JG, Lichtenstein AH, Goff DC Jr, Lloyd-Jones DM, Smith SC Jr, Blum C, Schwartz JS. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med 2014; 160: 339-43.
3. McIntosh MS, Kumar V, Kalynych C, Lott M, Hsi A, Chang JL, Lerman RH. Racial differences in blood lipids lead to underestimation of cardiovascular risk in black women in a nested observational study. Glob Adv Health Med 2013; 2: 76-9.
4. People’s Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group: An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People’s Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation 1992; 85: 1083-96.
5. Huang P, Yin RX, Huang KK, Zeng XN, Guo T, Lin QZ, Wu J, Wu DF, Li H, Pan SL. Association of the KLF14 rs4731702 SNP and serum lipid levels in the Guangxi Mulao and Han populations. Biomed Res Int 2013; 2013: 231515.
6. Hata Y, Nakajima K. Life-style and serum lipids and lipoproteins. J Atheroscler Thromb 2000; 7: 177-97.
7. Yin RX, Wu DF, Miao L, Aung LH, Cao XL, Yan TT, Long XJ, Liu WY, Zhang L, Li M. Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels. Cardiovasc Diabetol 2012; 11: 123.
8. Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011; 50: 372-87.
9. González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, Martínez- Clemente M, López-Parra M, Arroyo V, Clària J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB J 2009; 23: 1946-57.
10. Sener A, Zhang Y, Bulur N, Louchami K, Malaisse WJ, Carpentier YA. The metabolic syndrome of omega3-depleted rats. II. Body weight, adipose tissue mass and glycemic homeostasis. Int J Mol Med 2009; 24: 125-9.
11. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012; 308: 1024-33.
12. Parolini C, Manzini S, Busnelli M, Rigamonti E, Marchesi M, Diani E, Sirtori CR, Chiesa G. Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats. Br J Nutr 2013; 110: 1394-401.
13. Temme EH, Mensink RP, Hornstra G. Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr 1996; 63: 897-903.
14. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013; 5: 1218-40.
15. Franssen R, Monajemi H, Stroes ES, Kastelein JJ. Obesity and dyslipidemia. Med Clin North Am 2011; 95: 893-902.
16. Capell WH, Zambon A, Austin MA, Brunzell JD, Hokanson JE. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vasc Biol 1996; 16: 1040-6.
17. Hokanson JE, Krauss RM, Albers JJ, Austin MA, Brunzell JD. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 452-9.
18. Clemente-Postigo M, Queipo-Ortuño MI, Fernandez- Garcia D, Gomez-Huelgas R, Tinahones FJ, Cardona F. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One 2011; 6: e24783.
19. Klop B, Wouter Jukema J, Rabelink TJ, Castro Cabezas M. A physician’s guide for the management of hypertriglyceridemia: The etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med 2012; 54: 91-103.
20. Ruixing Y, Shangling P, Hong C, Hanjun Y, Hai W, Yuming C, Jinzhen W, Feng H, Meng L, Muyan L. Diet, alcohol consumption, and serum lipid levels of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. Alcohol 2008; 42: 219-29.
21. Waśkiewicz A, Sygnowska E. Alcohol intake and cardiovascular risk factor profile in men participating in the WOBASZ study. Kardiol Pol 2013; 71: 359-65.
22. Ruidavets JB, Ducimetière P, Arveiler D, Amouyel P, Bingham A, Wagner A, Cottel D, Perret B, Ferrières J. Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 2002; 56: 24-8.
23. Choudhury SR, Ueshima H, Kita Y, Kobayashi KM, Okayama A, Yamakawa M, Hirao Y, Ishikawa M, Miyoshi Y. Alcohol intake and serum lipids in a Japanese population. Int J Epidemiol 1994; 23: 940-7.
24. Perissinotto E, Buja A, Maggi S, Enzi G, Manzato E, Scafato E, Mastrangelo G, Frigo AC, Coin A, Crepaldi G, Sergi G; ILSA Working Group. Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: the Italian Longitudinal Study on Aging. Nutr Metab Cardiovasc Dis 2010; 20: 647-55.
25. Onat A, Hergenc G, Dursunoglu D, Ordu S, Can G, Bulur S, Yüksel H. Associations of alcohol consumption with blood pressure, lipoproteins, and subclinical inflammation among Turks. Alcohol 2008; 42: 593-601.
26. Rao Ch S, Subash YE. The effect of chronic tobacco smoking and chewing on the lipid profile. J Clin Diagn Res 2013; 7: 31-4.
27. Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ, Montori VM. Testosterone and cardiovascular risk in men: a systematic review and metaanalysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 29-39.
28. Guetta V, Cannon RO III. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996; 93: 1928-37.
29. Kelley GA, Kelley KS, Tran ZV. Aerobic exercise and lipids and lipoproteins in women: a metaanalysis of randomized controlled trials. J Womens Health (Larchmt) 2004; 13: 1148-64.
30. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension 2006; 47: 45-50.